Summary & Overview
CPT 77331: Special Radiation Dosimetry for Radiation Treatment
CPT code 77331 is designated for special radiation dosimetry, a procedure essential to the accurate measurement and calculation of radiation doses in cancer treatment. This code is widely used in outpatient hospital settings and plays a pivotal role in ensuring patient safety and treatment efficacy during radiation therapy. The publication provides a comprehensive overview of national coverage policies and billing practices for this code, focusing on major payers including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare.
Readers will gain insights into the clinical context of special radiation dosimetry, its importance in radiation oncology, and how it fits within broader medical billing and coding frameworks. The summary also addresses relevant benchmarks, policy updates, and the relationship between 77331 and other related codes, such as 77301, which bundles certain services under IMRT treatment planning. Key modifiers, associated taxonomies, and common ICD-10 diagnoses linked to this code are discussed, providing a well-rounded understanding of its application and reimbursement landscape. This article is intended for healthcare professionals, administrators, and policy analysts seeking up-to-date information on coding, coverage, and clinical relevance for special radiation dosimetry.
CPT Code Overview
CPT code 77331 represents special radiation dosimetry, a service within the field of medical radiation physics, dosimetry, treatment devices, and special services for radiation treatment. This procedure involves the measurement and calculation of radiation doses delivered to patients, ensuring precise and safe administration of radiation therapy. The typical site of service for this code is the outpatient hospital setting, designated as Place of Service 22. Special radiation dosimetry is a critical component in the management and treatment of various malignancies, supporting accurate and effective radiation therapy.
Clinical & Coding Specifications
Clinical Context
A patient diagnosed with a malignant neoplasm, such as breast cancer (C50.919), prostate cancer (C61), lung cancer (C34.90), colon cancer (C18.9), or brain cancer (C71.9), is referred to the outpatient hospital (Place of Service 22) for radiation therapy. As part of the treatment planning, special radiation dosimetry is performed to measure and calculate the precise dose of radiation to be delivered. This process involves medical radiation physics specialists, such as radiation oncology physicians, nuclear medicine physicians, or body imaging physicians, who ensure accurate dose calculation for effective and safe treatment.
Coding Specifications
-
Modifiers:
- Modifier
26: Used to indicate the professional component of the service, representing the physician's work in interpreting and reporting the dosimetry. - Modifier
TC: Used to indicate the technical component, representing the provision of equipment, supplies, and technical staff required for the dosimetry procedure.
- Modifier
-
Provider Taxonomies:
| Taxonomy Code | Specialty Name |
|---|---|
| 2085R0001X | Radiation Oncology Physician |
| 2085N0904X | Nuclear Medicine Physician |
| 2085B0100X | Body Imaging Physician |
These specialties are typically involved in the performance and interpretation of special radiation dosimetry.
Related Diagnoses
-
C50.919: Malignant neoplasm of unspecified site of unspecified female breast- Relevant for patients undergoing radiation dosimetry as part of breast cancer treatment planning.
-
C61: Malignant neoplasm of prostate- Indicates prostate cancer, where special dosimetry is used to ensure accurate radiation delivery.
-
C34.90: Malignant neoplasm of unspecified part of unspecified bronchus or lung- Used for lung cancer cases requiring precise radiation dose calculation.
-
C18.9: Malignant neoplasm of colon, unspecified- Applies to colon cancer patients receiving radiation therapy.
-
C71.9: Malignant neoplasm of brain, unspecified- Relevant for brain cancer cases where special dosimetry is critical for treatment safety and efficacy.
Related CPT Codes
77301: IMRT treatment planning (development of an IMRT plan) — other listed services including CPT code77331are bundled into payment for77301and should not be reported in addition when provided as part of the IMRT plan.
77301 is used for intensity-modulated radiation therapy (IMRT) planning. When 77331 is performed as part of the IMRT plan, it is not separately billable, as its payment is included in 77301. These codes are related in the workflow of radiation treatment planning, with 77331 representing a component service that is bundled under 77301 for IMRT.
National Reimbursement Benchmarks
Nationally, the mean rate for CPT code 77331 under Medicare is $44.86, while the average commercial mean rate (BUCA) is $60.46. This highlights a notable gap between Medicare and commercial reimbursement levels for this service.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Medicare shows the widest spread at $42.00, indicating significant variability in rates. In contrast, Aetna has the tightest range at $16.42, suggesting more consistent reimbursement levels. Blue Cross Blue Shield, Cigna, and UnitedHealth Group all exhibit moderate dispersion, with ranges between $31.00 and $36.00.
The table and chart below present a detailed breakdown of national mean rates and percentile values for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.